TCL Archive In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available July 1, 1977
TCL Archive Volasertib Shows Response In 31 Percent of Acute Myeloid Leukemia Patients December 28, 2012
TCL Archive Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say July 24, 2009